Faculty of Medicine, Hasanuddin University, Makassar, South Sulawesi, 90222, Indonesia.
Department of Urology, Faculty of Medicine, Hasanuddin University, Makassar, South Sulawesi, 90245, Indonesia.
F1000Res. 2021 Feb 11;10:104. doi: 10.12688/f1000research.28346.1. eCollection 2021.
There is increasing evidence that nephrolithiasis is a systemic disease, as opposed to an isolated urinary metabolic problem, after considerable links were found between nephrolithiasis and systemic diseases such as hypertension, obesity, dyslipidemia, and insulin resistance. The interplay between these four factors defines metabolic syndrome (MetS). In this review we aim to clarify the associations of MetS and its components to kidney stone incident. Online databases of EMBASE, MEDLINE, and Google Scholar were searched from January 1998 up to October 2020 to identify observational studies examining the association between metabolic syndrome components and kidney stone incident. Bayesian random-effects meta-analysis and meta-regression were performed to observe the association. Linear dose-response analysis was conducted to shape the direction of the association. Data analysis was performed using STATA, and R statistics. A total of 25 potentially relevant studies (n = 934,588 participants) were eventually identified. The pooled results suggested that metabolic syndrome was associated with an increased risk of nephrolithiasis with an odds ratio (OR) of 1.769 (95% CI: 1.386 - 2.309). The summary OR of hypertension and dyslipidemia for developing nephrolithiasis were 1.613 (95% CI: 1.213 - 2.169) and 1.586 (95% CI: 1.007 - 2.502) respectively. The presence of diabetes mellitus and obesity had an OR of 1.552 (95% CI: 1.027 - 2.344) and 1.531 (95% CI: 1.099 - 2.109) respectively. Our results revealed that the increasing number of MetS traits will increase the risk of developing nephrolithiasis, the higher the fasting plasma glucose, and body mass index, the higher the risk of kidney stones incident. Our results suggest that hypertension, diabetes, obesity and dyslipidemia are associated with increased risk of developing nephrolithiasis. Linear significant association between MetS components and nephrolithiasis were revealed in our study which reinforced the notion that should be considered a systemic disorder.
越来越多的证据表明,肾结石不仅仅是一种孤立的尿路代谢问题,而是一种全身性疾病,因为在肾结石与高血压、肥胖、血脂异常和胰岛素抵抗等全身性疾病之间发现了相当多的联系。这四个因素的相互作用定义了代谢综合征(MetS)。在这篇综述中,我们旨在阐明代谢综合征及其成分与肾结石发病之间的关联。我们在 EMBASE、MEDLINE 和 Google Scholar 的在线数据库中进行了搜索,检索了 1998 年 1 月至 2020 年 10 月期间观察性研究,以确定研究代谢综合征成分与肾结石发病之间关系的研究。我们进行了贝叶斯随机效应荟萃分析和荟萃回归,以观察相关性。我们进行了线性剂量-反应分析,以确定相关性的方向。数据分析使用 STATA 和 R 统计软件进行。最终确定了 25 项潜在相关的研究(n = 934588 名参与者)。汇总结果表明,代谢综合征与肾结石的发病风险增加相关,比值比(OR)为 1.769(95%可信区间:1.386-2.309)。高血压和血脂异常导致肾结石发病的汇总 OR 分别为 1.613(95%可信区间:1.213-2.169)和 1.586(95%可信区间:1.007-2.502)。糖尿病和肥胖的存在的 OR 分别为 1.552(95%可信区间:1.027-2.344)和 1.531(95%可信区间:1.099-2.109)。我们的结果表明,代谢综合征特征数量的增加会增加肾结石发病的风险,空腹血糖和体重指数越高,肾结石发病的风险越高。我们的结果表明,高血压、糖尿病、肥胖和血脂异常与肾结石发病风险增加相关。在我们的研究中揭示了代谢综合征成分与肾结石之间存在线性显著关联,这强化了这样一种观点,即代谢综合征应被视为一种全身性疾病。